LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.66 | 770.25 | 1106 | 1090 | 1.0147 | 1.0590 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.66 | 770.25 | 1120 | 1090 | 1.0275 | 1.1114 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.06 | 770.25 | 1135 | 1218 | 0.9315 | 0.7966 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.06 | 770.25 | 1151 | 1218 | 0.9446 | 0.8350 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.28 | 770.25 | 1165 | 1358 | 0.8578 | 0.6581 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.28 | 770.25 | 1193 | 1358 | 0.8784 | 0.7070 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.50 | 770.25 | 1199 | 1497 | 0.8008 | 0.5864 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.50 | 770.25 | 1236 | 1497 | 0.8255 | 0.6375 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.73 | 770.25 | 1220 | 1664 | 0.7330 | 0.5124 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.73 | 770.25 | 1275 | 1664 | 0.7660 | 0.5736 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.95 | 770.25 | 1270 | 1832 | 0.6930 | 0.4917 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.95 | 770.25 | 1258 | 1832 | 0.6865 | 0.4804 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.17 | 770.25 | 1305 | 2008 | 0.6498 | 0.4642 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.17 | 770.25 | 1305 | 2008 | 0.6498 | 0.4642 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.39 | 770.25 | 1314 | 2244 | 0.5854 | 0.4136 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 23.39 | 770.25 | 1296 | 2244 | 0.5774 | 0.4010 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.62 | 770.25 | 1280 | 2514 | 0.5090 | 0.3465 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.62 | 770.25 | 1311 | 2514 | 0.5213 | 0.3655 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.84 | 770.25 | 1334 | 2833 | 0.4707 | 0.3394 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.84 | 770.25 | 1330 | 2833 | 0.4693 | 0.3373 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.06 | 770.25 | 1271 | 3106 | 0.4092 | 0.2827 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.06 | 770.25 | 1246 | 3106 | 0.4011 | 0.2701 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.28 | 770.25 | 1226 | 3392 | 0.3614 | 0.2427 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.28 | 770.25 | 1333 | 3392 | 0.3929 | 0.2923 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.50 | 770.25 | 1213 | 3712 | 0.3268 | 0.2216 | MN20160304_L02 | J14 |